Chemoinformaics analysis of 4-Hydroxybenzoylcholine
| Molecular Weight | 224.28 | nRot | 4 |
| Heavy Atom Molecular Weight | 206.136 | nRig | 7 |
| Exact Molecular Weight | 224.128 | nRing | 1 |
| Solubility: LogS | 0.649 | nHRing | 0 |
| Solubility: LogP | -0.791 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 35.5483 |
| nHD | 1 | BPOL | 22.9417 |
| QED | 0.618 |
| Synth | 2.113 |
| Natural Product Likeliness | 0.553 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.013 |
| HIA | 0.96 |
| CACO-2 | -5.619 |
| MDCK | 0.0000364 |
| BBB | 0.443 |
| PPB | 0.153839 |
| VDSS | 1.289 |
| FU | 0.712749 |
| CYP1A2-inh | 0.031 |
| CYP1A2-sub | 0.915 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.585 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.911 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.088 |
| CL | 6.393 |
| T12 | 0.954 |
| hERG | 0.076 |
| Ames | 0.005 |
| ROA | 0.141 |
| SkinSen | 0.055 |
| Carcinogencity | 0.026 |
| EI | 0.155 |
| Respiratory | 0.06 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.555502 |